The NHLBI Catalyze Program supports investigators developing early-stage diagnostics, devices, small molecules, biologics, and research tools for heart, lung, blood, and sleep (HLBS) disorders. Join Catalyze leadership on January 9, 2026 at 2:00 p.m. ET for a programmatic webinar designed to help prospective applicants determine whether the Catalyze program is the right fit for their translational research or technology development efforts.

Participants will learn about the different mechanisms of support Catalyze offers based on a project’s stage of development, and how to identify the pathway that best aligns with their technology.

To register, visit the registration page here.